Cancer
HER-2/neu 435-443 (HLA-A*02:01) ILHNGAYSL
Product number: EP11232_5
€210.00*
Prices excl. VAT plus shipping
costs
Available, delivery time:
1-3 days
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Purity:
95% HPLC-MS
Caution:
For research use only. Not for use in humans.
Amount in mg
1
Description
The peptide HER-2/neu 435-443 (HLA-A*02:01) with the amino acid sequence ILHNGAYSL is a linear peptidic epitope (epitope ID 27094) studied as part of Receptor tyrosine-protein kinase erbB-2 (UniProt:P04626) from Homo sapiens (human).
HER-2/neu 435-443 (HLA-A*02:01) has been studied for immune reactivity in publications and has been tested in T cell assays and MHC ligand assays.
TechData
| Sequence: | ILHNGAYSL |
| Gene: | ERBB2 |
| Delivery: | 1-3 days |
| C-Terminus: | OH |
| N-Terminus: | H |
| Amount: | 5 mg |
| Counterion: | TFA |
| Protein: | Receptor tyrosine-protein kinase erbB-2 |
| Species: | Human |
| Allele: | HLA-A*02:01 |
| Application: | T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
| Indication: | Cancer |
| Purity: | 95% HPLC-MS |